Ensign Peak Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Hold |
6,445
| – | – | ﹤0.01% | 1681 |
|
|
2025
Q1 | $174K | Hold |
6,445
| – | – | ﹤0.01% | 1676 |
|
|
2024
Q4 | $231K | Hold |
6,445
| – | – | ﹤0.01% | 1692 |
|
|
2024
Q3 | $244K | Hold |
6,445
| – | – | ﹤0.01% | 1683 |
|
|
2024
Q2 | $292K | Hold |
6,445
| – | – | ﹤0.01% | 1681 |
|
|
2024
Q1 | $313K | Sell |
6,445
-325
| -5% | -$15.8K | ﹤0.01% | 1689 |
|
|
2023
Q4 | $363K | Hold |
6,770
| – | – | ﹤0.01% | 1696 |
|
|
2023
Q3 | $397K | Hold |
6,770
| – | – | ﹤0.01% | 1648 |
|
|
2023
Q2 | $427K | Hold |
6,770
| – | – | ﹤0.01% | 1661 |
|
|
2023
Q1 | $426K | Buy |
6,770
+900
| +15% | +$56.6K | ﹤0.01% | 1673 |
|
|
2022
Q4 | $312K | Buy |
5,870
+1,900
| +48% | +$101K | ﹤0.01% | 1705 |
|
|
2022
Q3 | $223K | Sell |
3,970
-30
| -0.8% | -$1.69K | ﹤0.01% | 1836 |
|
|
2022
Q2 | $289K | Hold |
4,000
| – | – | ﹤0.01% | 1695 |
|
|
2022
Q1 | $318K | Hold |
4,000
| – | – | ﹤0.01% | 1732 |
|
|
2021
Q4 | $405K | Sell |
4,000
-7,700
| -66% | -$780K | ﹤0.01% | 1697 |
|
|
2021
Q3 | $1.08M | Hold |
11,700
| – | – | ﹤0.01% | 1403 |
|
|
2021
Q2 | $1.2M | Hold |
11,700
| – | – | ﹤0.01% | 1370 |
|
|
2021
Q1 | $1.14M | Buy |
11,700
+600
| +5% | +$58.6K | ﹤0.01% | 1375 |
|
|
2020
Q4 | $856K | Hold |
11,100
| – | – | ﹤0.01% | 1459 |
|
|
2020
Q3 | $818K | Hold |
11,100
| – | – | ﹤0.01% | 1395 |
|
|
2020
Q2 | $815K | Hold |
11,100
| – | – | ﹤0.01% | 1339 |
|
|
2020
Q1 | $641K | Hold |
11,100
| – | – | ﹤0.01% | 1319 |
|
|
2019
Q4 | $872K | Buy |
+11,100
| New | +$872K | ﹤0.01% | 1381 |
|